[1]

ACOG. 2021. Fetal growth restriction: ACOG practice bulletin, Number 227. Obstetrics and Gynecology 137:e16−e28

doi: 10.1097/AOG.0000000000004251
[2]

Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. 2023. Births: Final Data for 2021. National Vital Statistics Reports. USA: Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. pp. 1–53 https://pubmed.ncbi.nlm.nih.gov/36723449

[3]

Wallace ME, Mendola P, Liu D, Grantz KL. 2015. Joint effects of structural racism and income inequality on small-for-gestational-age birth. American Journal of Public Health 105:1681−1688

doi: 10.2105/ajph.2015.302613
[4]

Díez López I, Cernada M, Galán L, Boix H, Ibañez L, et al. 2024. Small for gestational age: concept, diagnosis and neonatal characterization, follow-up and recommendations. Anales de Pediatría (English Edition) 101:124−131

doi: 10.1016/j.anpede.2024.07.012
[5]

Minor KC, Bianco K, Sie L, Druzin ML, Lee HC, et al. 2023. Severity of small-for-gestational-age and morbidity and mortality among very preterm neonates. Journal of Perinatology 43:437−444

doi: 10.1038/s41372-022-01544-w
[6]

O'Brien M, Gilchrist C, Sadler L, Hegarty JE, Alsweiler JM. 2023. Infants eligible for neonatal hypoglycemia screening: a systematic review. JAMA Pediatrics 177:1187−1196

doi: 10.1001/jamapediatrics.2023.3957
[7]

Surkan PJ, Hong X, Zhang B, Nawa N, Ji H, et al. 2020. Can social support during pregnancy affect maternal DNA methylation? Findings from a cohort of African-Americans. Pediatric Research 88:131−138

doi: 10.1038/s41390-019-0512-7
[8]

Quinn EB, Hsiao CJ, Maisha FM, Mulligan CJ. 2023. Prenatal maternal stress is associated with site-specific and age acceleration changes in maternal and newborn DNA methylation. Epigenetics 18:2222473

doi: 10.1080/15592294.2023.2222473
[9]

Leeuwerke M, Eilander MS, Pruis MGM, Lendvai Á, Erwich JJHM, et al. 2016. DNA methylation and expression patterns of selected genes in first-trimester placental tissue from pregnancies with small-for-gestational-age infants at birth. Biology of Reproduction 94:e37

doi: 10.1095/biolreprod.115.131698
[10]

Kim SY, Kim HJ, Park SY, Lee DE, Kim KS, et al. 2015. Quantification of the placental epigenetic signature of the SERPINB5 gene in maternal plasma of pregnancies complicated by small for gestational age. Placenta 36:131−137

doi: 10.1016/j.placenta.2014.09.020
[11]

Aghagoli G, Sheinkopf SJ, Everson TM, Marsit CJ, Lee H, et al. 2021. Epigenome-wide analysis identifies genes and pathways linked to acoustic cry variation in preterm infants. Pediatric Research 89:1848−1854

doi: 10.1038/s41390-020-01172-0
[12]

Haas DM, Parker CB, Wing DA, Parry S, Grobman WA, et al. 2015. A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b). American Journal of Obstetrics and Gynecology 212:539.e1−539.e24

doi: 10.1016/j.ajog.2015.01.019
[13]

Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. 2003. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatrics 3:6

doi: 10.1186/1471-2431-3-6
[14]

Yang HH, Han MR. 2024. MethylCallR: a comprehensive analysis framework for Illumina Methylation Beadchip. Scientific Reports 14:27026

doi: 10.1038/s41598-024-77914-5
[15]

Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, et al. 2014. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363−1369

doi: 10.1093/bioinformatics/btu049
[16]

Chen Y, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, et al. 2013. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:203−209

doi: 10.4161/epi.23470
[17]

Cavalcante RG, Sartor MA. 2017. Annotatr: genomic regions in context. Bioinformatics 33:2381−2383

doi: 10.1093/bioinformatics/btx183
[18]

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, et al. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43:e47

doi: 10.1093/nar/gkv007
[19]

Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, et al. 2023. G: profiler—interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Research 51:W207−W212

doi: 10.1093/nar/gkad347
[20]

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. 2000. Gene Ontology: tool for the unification of biology. Nature Genetics 25:25−29

doi: 10.1038/75556
[21]

Kanehisa M, Goto S. 2000. KEGG Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28:27−30

doi: 10.1093/nar/28.1.27
[22]

Milacic M, Beavers D, Conley P, Gong C, Gillespie M, et al. 2024. The reactome pathway knowledgebase 2024. Nucleic Acids Research 52:D672−D678

doi: 10.1093/nar/gkad1025
[23]

Lawless L, Qin Y, Xie L, Zhang K. 2023. Trophoblast differentiation: mechanisms and implications for pregnancy complications. Nutrients 15:3564

doi: 10.3390/nu15163564
[24]

Masserdotti A, Gasik M, Grillari-Voglauer R, Grillari J, Cargnoni A, et al. 2024. Unveiling the human fetal-maternal interface during the first trimester: biophysical knowledge and gaps. Frontiers in Cell and Developmental Biology 12:1411582

doi: 10.3389/fcell.2024.1411582
[25]

Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, et al. 2020. The placenta in fetal growth restriction: what is going wrong? Placenta 96:10−18

doi: 10.1016/j.placenta.2020.05.003
[26]

Apicella C, Ruano CSM, Méhats C, Miralles F, Vaiman D. 2019. The role of epigenetics in placental development and the etiology of preeclampsia. International Journal of Molecular Sciences 20:2837

doi: 10.3390/ijms20112837
[27]

Rosenfeld CS. 2024. Placenta extracellular vesicles: messengers connecting maternal and fetal systems. Biomolecules 14:995

doi: 10.3390/biom14080995
[28]

Wang W, Wang S, Xu AM, Yuan X, Huang L, et al. 2021. Overexpression of GSE1 related to trastuzumab resistance in gastric cancer cells. BioMed Research International 2021:8834923

doi: 10.1155/2021/8834923
[29]

Hiver S, Shimizu-Mizuno N, Ikawa Y, Kajikawa E, Sai X, et al. 2023. Gse1, a component of the CoREST complex, is required for placenta development in the mouse. Developmental Biology 498:97−105

doi: 10.1016/j.ydbio.2023.03.009
[30]

Lamber EP, Guicheney P, Pinotsis N. 2022. The role of the M-band myomesin proteins in muscle integrity and cardiac disease. Journal of Biomedical Science 29:18

doi: 10.1186/s12929-022-00801-6
[31]

Auxerre-Plantié E, Nielsen T, Grunert M, Olejniczak O, Perrot A, et al. 2020. Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart. Disease Models & Mechanisms 13:dmm045377

doi: 10.1242/dmm.045377
[32]

Winerdal M, Westenius E, Granfors M, Pettersson M, Iwarsson E. 2020. Confined placental mosaicism of Duchenne muscular dystrophy: a case report. Molecular Cytogenetics 13:51

doi: 10.1186/s13039-020-00520-3
[33]

Dai C, Tong Y, Bai N, Xu N, Zhao X, et al. 2025. Decoding the role of nucleic acid binding protein 2 in lipid dysregulation and hepatocellular carcinoma progression through LKB1-mediated mitochondrial dysfunction. Cellular Signalling 132:111820

doi: 10.1016/j.cellsig.2025.111820
[34]

Dang Q, Zhu Y, Zhang Y, Hu Z, Wei Y, et al. 2024. Nuclear binding protein 2/nesfatin-1 affects trophoblast cell fusion during placental development via the EGFR-PLCG1-CAMK4 pathway. International Journal of Molecular Sciences 25:1925

doi: 10.3390/ijms25031925
[35]

Court MH, Hazarika S, Krishnaswamy S, Finel M, Williams JA. 2008. Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Molecular Pharmacology 74:744−754

doi: 10.1124/mol.108.045500
[36]

Collier AC, Yamauchi Y, Sato BLM, Rougée LRA, Ward MA. 2014. UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst. Drug Metabolism and Disposition 42:1921−1925

doi: 10.1124/dmd.114.059766
[37]

Yao C, Yang C, Zhao L, Li P, Tian R, et al. 2021. Bi-allelic SHOC1 loss-of-function mutations cause meiotic arrest and non-obstructive azoospermia. Journal of Medical Genetics 58:679−686

doi: 10.1136/jmedgenet-2020-107042
[38]

Zadeh N, Graham JM. 1993. KCNK9 Imprinting Syndrome. In GeneReviews®, ed. Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, et al. Seattle, WA: University of Washington. pp. 1−16 www.ncbi.nlm.nih.gov/books/NBK425128/pdf/Bookshelf_NBK425128.pdf

[39]

Janssen BG, Godderis L, Pieters N, Poels K, Kiciński M, et al. 2013. Placental DNA hypomethylation in association with particulate air pollution in early life. Particle and Fibre Toxicology 10:22

doi: 10.1186/1743-8977-10-22
[40]

Bekkering I, Leeuwerke M, Tanis JC, Schoots MH, Verkaik-Schakel RN, et al. 2019. Differential placental DNA methylation of VEGFA and LEP in small-for-gestational age fetuses with an abnormal cerebroplacental ratio. PLoS One 14:e0221972

doi: 10.1371/journal.pone.0221972
[41]

Filiberto AC, Maccani MA, Koestler DC, Wilhelm-Benartzi C, Avissar-Whiting M, et al. 2011. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 6:566−572

doi: 10.4161/epi.6.5.15236
[42]

Tobi EW, Heijmans BT, Kremer D, Putter H, Delemarre-van de Waal HA, et al. 2011. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics 6:171−176

doi: 10.4161/epi.6.2.13516
[43]

Collier AY, Ledyard R, Montoya-Williams D, Qiu M, Dereix AE, et al. 2021. Racial and ethnic representation in epigenomic studies of preterm birth: a systematic review. Epigenomics 13:1735−1746

doi: 10.2217/epi-2020-0007
[44]

Reforma L, Greenberg S, Ledyard R, Burris H. 2024. Equitable representation of race, ethnicity, and ancestry among genomic studies of preterm birth: a systematic review. Cureus 16:e53757

doi: 10.7759/cureus.53757
[45]

Loyfer N, Magenheim J, Peretz A, Cann G, Bredno J, et al. 2023. A DNA methylation atlas of normal human cell types. Nature 613:355−364

doi: 10.1038/s41586-022-05580-6
[46]

Stone A, Zotenko E, Locke WJ, Korbie D, Millar EKA, et al. 2015. DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer. Nature Communications 6:7758

doi: 10.1038/ncomms8758
[47]

Li L, Lee KM, Han W, Choi JY, Lee JY, et al. 2010. Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Human Molecular Genetics 19:4273−4277

doi: 10.1093/hmg/ddq351
[48]

Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, et al. 2016. Genome-wide DNA methylation levels and altered Cortisol stress reactivity following childhood trauma in humans. Nature Communications 7:10967

doi: 10.1038/ncomms10967